News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Molecular Targeting Technologies, Inc. Licenses Robust Near-infrared (NIR) Dye Technology from the Massachusetts General Hospital/Harvard Medical School


5/10/2011 10:17:16 AM

WEST CHESTER, Pa.--(BUSINESS WIRE)--Molecular Targeting Technologies, Inc., (MTTI) announced that it has obtained an exclusive license from the Massachusetts General Hospital for novel fluorescence dyes developed by Scott Hilderbrand, Ph.D. Fangwei Shao, Ph.D., and Ralph Weissleder, Ph.D. M.D.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES